2013 American Transplant Congress
Belatacept Post-Approval Implementation: A Large Single Center Experience
Emory Transplant Center, Atlanta, GA; Bristol-Myers Squibb, Princeton, NJ
Belatacept is a novel CD28 pathway antagonist that was recently approved as a maintenance immunosuppressive agent for kidney transplant recipients. While the pivotal trials for…2013 American Transplant Congress
Normative Values for Transplant Health-Related Quality of Life
Background. Health-related quality of life (HRQoL) evaluates health from the view point of the individual and preferences the “quality of live versus the quantity of…2013 American Transplant Congress
False Hepatitis C Antibody Development in Left Ventricular Assist Device Recipients Who Proceed to Heart Transplantation
Purpose: Ventricular assist devices (VAD) have been shown to lead to immune activation and higher frequencies of autoantibodies. Previous research reports a rate of 30%…2013 American Transplant Congress
Altered Serum miR-326 and miR-142-3p Profiles during Acute Rejection after Heart Transplantation
IntroductionCirculating miRNAs may serve the purpose as practicable non-invasive biological marker of allograft status in heart transplanted patients, as they can be detected in serum…2013 American Transplant Congress
Rituximab To Prevent Renal Allograft Rejection; a Randomized, Double-Blind, Placebo-Controlled Trial
BackgroundAnti-B-cell therapy could reduce the incidence of acute renal allograft rejection, especially in immunized patients. This study evaluated the efficacy and safety of rituximab added…2013 American Transplant Congress
Thymoglobulin (rATG) Induction Improves Survival in Heart Transplant Recipients: A Retrospective Single-Center Study
A: Our study is a retrospective analysis of heart transplant recipients transplanted in 2009 and were induced with rATG vs. no induction. We hypothesized that…2013 American Transplant Congress
Time in the Operating Room Independently Predicts Blood Utilization, Charges, and a Cost Efficient Practice
Center for Transplantation, University of Kansas Medical Center, Kansas City, KS
BACKGROUND: In an era of economic reform we see clinical practice under increasing performance oversight. To date few studies that have looked specifically at clinical…2013 American Transplant Congress
Comparison of Histamine Receptor Antagonists Versus Proton Pump Inhibitor Stress Ulcer Prophylaxis in Kidney Transplant Recipients, A
Purpose: Histamine-2 receptor antagonists (H2RA) or proton pump inhibitors (PPI) are often utilized for stress ulcer prophylaxis in kidney transplant (KTx) recipients. The purpose of…2013 American Transplant Congress
IL21 Plays a Critical Role in Chronic Rejection but Not in Acute or Accelerated Allograft Rejection
University of Toledo College of Medicine, Toledo
There is mounting evidence that IL21 may be a specialized cytokine that controls chronic rather than acute immune responses. Herein, we evaluated the role of…2013 American Transplant Congress
Monocyte FcγRIIa Allotype Influences Recruitment to Endothelial Cells Triggered by HLA I Antibodies
Pathology and Laboratory Medicine, UCLA, Los Angeles, CA
Background: HLA I antibody (Ab) activation of endothelial cells (EC) promotes monocyte recruitment through P-selectin and FcΓRI and FcΓRIIa. Human FcΓRIIa is dimorphic. R131 allele…
American Transplant Congress abstracts